error
Divisa

RHEUMATOLOGY, 2-VOLUME SET

, ,
9780323091381 ::  RHEUMATOLOGY, 2-VOLUME SET
ISBN:

9780323091381

Toms:2
EditorialELSEVIER SCIENCE PUB.B.U.
Edició:
Pàgines:1976
Il·lustrat:Si
Idioma:INGLES
Consultar
Entrega en 15 dies

<P>STAY CURRENT IN THE EVER-CHANGING DISCIPLINE OF RHEUMATOLOGY WITH CLEAR, RELIABLE GUIDANCE FROM HOCHBERG?S RHEUMATOLOGY, ONE OF THE MOST RESPECTED AND TRUSTED SOURCES IN THE FIELD. DESIGNED TO MEET THE NEEDS OF THE PRACTICING CLINICIAN, THIS MEDICAL REFERENCE BOOK PROVIDES EXTENSIVE, AUTHORITATIVE COVERAGE OF RHEUMATIC DISEASES FROM BASIC SCIENTIFIC PRINCIPLES TO PRACTICAL POINTS OF CLINICAL MANAGEMENT IN A LUCID, LOGICAL, USER-FRIENDLY MANNER.</P> <P><I> "..A SPECTACULAR AND SEEMINGLY COMPREHENSIVE REVIEW OF RHEUMATOLOGY."</I> <B>REVIEWED BY</B> DR. HARRY BROWN, ON BEHALF OF GLYCOSMEDIA.COM, DECEMBER 2014</P>

<P><B>SECTION 1: THE SCIENTIFIC BASIS OF RHEUMATIC DISEASE</B></P> <P>1. EPIDEMIOLOGIC CONCEPTS AND THE CLASSIFICATION OF RHEUMATIC AND MUSCULOSKELETAL CONDITIONS </P> <P>2. PRINCIPLES OF CLINICAL OUTCOME ASSESSMENT</P> <P>3. PRINCIPLES OF HEALTH ECONOMICS AND APPLICATION TO RHEUMATIC DISORDERS</P> <P>4. THE SYNOVIUM<I> </P></I> <P>5. THE ARTICULAR CARTILAGE<I> </P></I> <P>6. BONE STRUCTURE AND FUNCTION<I> </P></I> <P>7. TENDONS AND LIGAMENTS</P> <P>8. CONNECTIVE TISSUE RESPONSES TO MECHANICAL STRESSES</P> <P>9. BIOMECHANICS OF PERIPHERAL JOINTS</P> <P>10. BIOMECHANICS OF THE SPINE<I> </P></I> <P>11. PRINCIPLES OF GENETIC EPIDEMIOLOGY<I> </P></I> <P>12. PRINCIPLES AND TECHNIQUES IN MOLECULAR BIOLOGY<I> </P></I> <P>13. CYTOKINES<I> </P></I> <P>14. SIGNAL TRANSDUCTION IN IMMUNE CELLS<I> </P></I> <P>15. THE PRINCIPLES OF ADAPTIVE IMMUNITY</P> <P>16. PRINCIPLES OF INNATE IMMUNITY<I> </P></I> <P>17. SYSTEMS BIOLOGY<I> </P></I> <P>18. EPIGENETICS IN RHEUMATOLOGY<I> </P></I> <P>19. THE MICROBIOME IN RHEUMATIC DISEASES<I> </P></I> <P>20. TISSUE DESTRUCTION AND REPAIR<I> </P></I> <P>21. PRINCIPLES OF TISSUE ENGINEERING AND CELL- AND GENE-BASED THERAPY<I> </P></I> <P>22. OSTEOIMMUNOLOGY<I> </P></I> <P>23. INFLAMMATION AND ITS MEDIATORS<I> </P></I> <P>24. SCIENTIFIC BASIS OF PAIN</P> <P>25. EFFECTS OF THE NEUROENDOCRINE SYSTEM ON DEVELOPMENT AND FUNCTION OF THE IMMUNE SYSTEM<I> </P></I> <P>26. INTERPRETING THE MEDICAL LITERATURE FOR THE RHEUMATOLOGIST: STUDY DESIGN AND LEVELS OF EVIDENCE</P> <P>27. ETHICS IN CLINICAL TRIALS<I> </P></I> <P><B>SECTION 2: CLINICAL BASIS OF RHEUMATIC DISEASE</B></P> <P>28. HISTORY AND PHYSICAL EXAMINATION</P> <P>29. PATTERN RECOGNITION IN ARTHRITIS</P> <P>30. ROLE OF LABORATORY TESTS IN RHEUMATIC DISORDERS<I> </P></I> <P>31. SYNOVIAL FLUID ANALYSIS<I> </P></I> <P>32. MINIMALLY INVASIVE PROCEDURES </P> <P>33. SKIN IN RHEUMATIC DISEASE<I> </P></I> <P>34. THE EYE IN RHEUMATIC DISEASE<I> </P></I> <P>35. THE HEART IN RHEUMATIC DISEASE<I> </P></I> <P>36. THE LUNG IN RHEUMATIC DISEASE<I> </P></I> <P>37. GASTROINTESTINAL TRACT AND RHEUMATIC DISEASE<I> </P></I> <P>38. THE KIDNEY AND RHEUMATIC DISEASE<I> </P></I> <P>39. THE NERVOUS SYSTEM IN RHEUMATIC DISEASE</P> <P><B>SECTION 3: EVALUATION: IMAGING TECHNIQUES</B></P> <P>40. CONVENTIONAL RADIOGRAPHY AND COMPUTED TOMOGRAPHY</P> <P>41. FUNCTIONAL MAGNETIC RESONANCE IMAGING </P> <P>42. MUSCULOSKELETAL ULTRASOUND</P> <P>43. BONE SCINTIGRAPHY AND POSITRON EMISSION TOMOGRAPHY<I> </P></I> <P>44. DUAL X-RAY ABSORPTIOMETRY AND MEASUREMENT OF BONE</P> <P>45. USE OF IMAGING AS AN OUTCOME MEASURE IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS IN CLINICAL TRIALS</P> <P><B>SECTION 4: PRINCIPLES OF MANAGEMENT</B></P> <P>46. ARTHRITIS PATIENT EDUCATION, HEALTH PROMOTION, AND TEAM APPROACHES TO MANAGEMENT<I> </P></I> <P>47. PRINCIPLES OF REHABILITATION: PHYSICAL AND OCCUPATIONAL THERAPY<I> </P></I> <P>48A. COMPLEMENTARY AND ALTERNATIVE MEDICINE<I> </P></I> <P>48B. PLACEBOS, CARING AND HEALING IN RHEUMATOLOGY<I> </P></I> <P>49. DRUG DEVELOPMENT</P> <P>50. NON-PHARMACOLOGIC PAIN MANAGEMENT<I> </P></I> <P>51. PHARMACOGENOMICS IN RHEUMATOLOGY </P> <P>52. PRINCIPLES OF OPIOID TREATMENT OF CHRONIC MUSCULOSKELETAL PAIN<I> </P></I> <P>53. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS</P> <P>54. SYSTEMIC GLUCOCORTICOIDS IN RHEUMATOLOGY<I> </P></I> <P>55. NONIMMUNOSUPPRESIVE DISEASE-MODIFYING ANTIRHEUMATIC DRUGS</P> <P>56. METHOTREXATE<I> </P></I> <P>57. LEFLUNOMIDE</P> <P>58. IMMUNOSUPPRESSIVES: CYCLOSPORINE, CYCLOPHOSPHAMIDE, AZATHIOPRINE, MYCOPHENOLATE MOFETIL<I> </P></I> <P>59. T-CELL COSTIMULATION AND OTHER DIRECTED THERAPIES</P> <P>60. B-CELL DEPLETION<I></P></I> <P>61. CYTOKINE NEUTRALIZERS: INTERLEUKIN-1 INHIBITORS</P> <P>62. INTERLEUKIN-6 INHIBITION<I> </P></I> <P>63. TUMOR NECROSIS FACTOR BLOCKING THERAPIES</P> <P>64. KINASE INHIBITION: A NEW THERAPEUTIC PRINCIPLE IN RHEUMATOLOGY</P> <P>65. EMERGING THERAPEUTIC TARGETS: GM-CSF, IL-17AND IL-23<I> </P></I> <P>66. BIOSIMILARS IN RHEUMATOLOGY</P> <P>67. INFECTIONS AND BIOLOGIC THERAPY IN RHEUMATOID ARTHRITIS: AN UPDATE ON RISK AND PREVENTION</P> <P>68. DRUGS AND PREGNANCY</P> <P>69. ASPIRATION AND INJECTION OF JOINTS AND PERIARTICULAR TISSUES AND INTRALESIONAL THERAPY<I> </P></I> <P>70. PERIOPERATIVE CARE OF PATIENTS WITH RHEUMATIC DISEASE</P> <P><B>SECTION 5: REGIONAL AND WIDESPREAD PAIN</B></P> <P>71. NECK PAIN</P> <P>72. LUMBAR SPINE DISORDERS<I> </P></I> <P>73. THE SHOULDER</P> <P>74. THE ELBOW<I> </P></I> <P>75. THE WRIST AND HAND<I> </P></I> <P>76. THE HIP<I> </P></I> <P>77. THE KNEE<I> </P></I> <P>78. THE ANKLE AND FOOT</P> <P>79. THE TEMPOROMANDIBULAR JOINT<I> </P></I> <P>80. FIBROMYALGIA AND RELATED SYNDROME</P> <P>81. ENTRAPMENT NEUROPATHIES AND COMPARTMENT SYNDROMES<I> </P></I> <P>82. COMPLEX REGIONAL PAIN SYNDROME (REFLEX SYMPATHETIC DYSTROPHY)</P> <P><B>SECTION 6: RHEUMATOID ARTHRITIS AND OTHER SYNOVIAL DISORDERS</B></P> <P>83. CLASSIFICATION AND EPIDEMIOLOGY OF RHEUMATOID ARTHRITIS<I> </P></I> <P>84. PRECLINICAL FEATURES OF RHEUMATOID ARTHRITIS<I> </P></I> <P>85. CLINICAL FEATURES OF RHEUMATOID ARTHRITIS</P> <P>86. EXTRA-ARTICULAR FEATURES OF RHEUMATOID ARTHRITIS AND SYSTEMIC INVOLVEMENT<I> </P></I> <P>87. ADULT-ONSET STILL'S DISEASE<I> </P></I> <P>88. IMAGING OF RHEUMATOID ARTHRITIS</P> <P>89. THE CONTRIBUTION OF GENETIC FACTORS TO RHEUMATOID ARTHRITIS</P> <P>90. ANIMAL MODELS OF ARTHRITIS</P> <P>91. AUTOANTIBODIES IN RHEUMATOID ARTHRITIS</P> <P>92. CELLULAR IMMUNITY IN RHEUMATOID ARTHRITIS</P> <P>93. ANGIOGENESIS AND VASCULOGENESIS IN RHEUMATOID ARTHRITIS<I> </P></I> <P>94. THE RHEUMATOID JOINT: SYNOVITIS AND TISSUE DESTRUCTION<I> </P></I> <P>95. EVALUATION AND MANAGEMENT OF EARLY INFLAMMATORY POLYARTHRITIS</P> <P>96. EVALUATION AND OUTCOMES OF PATIENTS WITH RHEUMATOID ARTHRITIS<I> </P></I> <P>97. MANAGEMENT OF RHEUMATOID ARTHRITIS: SYNOVITIS<I> </P></I> <P>98. MULTIDISCIPLINARY APPROACH TO RHEUMATOID ARTHRITIS<I> </P></I> <P><B>SECTION 7: PEDIATRIC RHEUMATOLOGY</B></P> <P>99A. EVALUATION OF MUSCULOSKELETAL COMPLAINTS IN CHILDREN: CLINICAL EVALUATION<I> </P></I> <P>99B. EVALUATION OF MUSCULOSKELETAL COMPLAINTS IN CHILDREN: NON-INFLAMMATORY MUSCULOSKELETAL DISORDERS</P> <P>100. CLASSIFICATION AND EPIDEMIOLOGY OF JUVENILE IDIOPATHIC ARTHRITIS</P> <P>101. CLINICAL FEATURES OF JUVENILE IDIOPATHIC ARTHRITIS </P> <P>102. ETIOLOGY AND PATHOGENESIS OF JUVENILE IDIOPATHIC ARTHRITIS</P> <P>103. MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS<I> </P></I> <P>104. THE JUVENILE-ONSET SPONDYLOARTHROPATHIES</P> <P>105. CONNECTIVE TISSUES DISEASES IN CHILDREN<I> </P></I> <P>106. REHABILITATION AND PSYCHOSOCIAL ISSUES IN JUVENILE IDIOPATHIC ARTHRITIS<I> </P></I> <P><B>SECTION 8: INFECTION-RELATED RHEUMATIC DISEASES</B></P> <P>107. INFECTIOUS ARTHRITIS I: BACTERIAL ARTHRITIS<I> </P></I> <P>108. INFECTIOUS ARTHRITIS II: MYCOBACTERIUM, BRUCELLA, FUNGAL, AND PARASITIC ARTHRITIS<I></P></I> <P>109. LYME DISEASE</P> <P>110. RHEUMATOLOGIC ASPECTS OF VIRAL INFECTIONS<I> </P></I> <P>111. ACUTE RHEUMATIC FEVER<I> </P></I> <P>112. REACTIVE ARTHRITIS</P> <P><B>SECTION 9: SPONDYLOARTHROPATHIES</B></P> <P>113. CLASSIFICATION AND EPIDEMIOLOGY OF SPONDYLOARTHRITIS</P> <P>114. CLINICAL FEATURES OF AXIAL SPONDYLARTHRITIS</P> <P>115. ETIOLOGY, PATHOGENESIS, AND PATHOPHYSIOLOGY OF ANKYLOSING SPONDYLITIS</P> <P>116. GENETICS OF AXIAL SPONDYLOARTHRITIS<I> </P></I> <P>117. IMAGING OF SPONDYLOARTHRITIS<I> </P></I> <P>118. MANAGEMENT OF ANKYLOSING SPONDYLITIS/AXIAL SPONDYLOARTHRITIS</P> <P>119. CLASSIFICATION AND EPIDEMIOLOGY OF PSORIATIC ARTHRITIS</P> <P>120. CLINICAL FEATURES OF PSORIATIC ARTHRITIS<I> </P></I> <P>121. ETIOLOGY AND PATHOGENESIS OF PSORIATIC ARTHRITIS<I> </P></I> <P>122. MANAGEMENT OF PSORIATIC ARTHRITIS<I> </P></I> <P>123. ENTHESOPATHIES<I> </P></I> <P><B>SECTION 10: CONNECTIVE TISSUE DISORDERS</B></P> <P>124. EPIDEMIOLOGY AND CLASSIFICATION OF SYSTEMIC LUPUS ERYTHEMATOSUS<I> </P></I> <P>125. PRECLINICAL FEATURES OF LUPUS</P> <P>126. CLINICAL FEATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS<I> </P></I> <P>127. GENETICS OF LUPUS<I> </P></I> <P>128. IMMUNOPATHOLOGY OF SYSTEMIC LUPUS ERYTHEMATOSUS<I> </P></I> <P>129. ANIMAL MODELS OF LUPUS</P> <P>130. AUTOANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS<I> </P></I> <P>131. PATHOGENESIS OF LUPUS<I> </P></I> <P>132. DRUG-INDUCED LUPUS<I> </P></I> <P>133. ASSESSING DISEASE ACTIVITY AND OUTCOME IN SYSTEMIC LUPUS ERYTHEMATOSUS<I> </P></I> <P>134. MANAGEMENT OF NON-RENAL/NON-CENTRAL NERVOUS SYSTEM LUPUS</P> <P>135. TREATMENT OF NEUROPSYCHIATRIC LUPUS<I> </P></I> <P>136. SYSTEMIC LUPUS ERYTHEMATOSUS: TREATMENT—RENAL INVOLVEMENT<I> </P></I> <P>137. SYSTEMIC LUPUS ERYTHEMATOSUS IN THE PREGNANT PATIENT AND NEONATAL LUPUS<I> </P></I> <P>138. SJÖGREN SYNDROME<I> </P></I> <P>139. ANTIPHOSPHOLIPID SYNDROME: OVERVIEW OF PATHOGENSIS, DIAGNOSIS, AND MANAGEMENT<I> </P></I> <P>140. CLASSIFICATION AND EPIDEMIOLOGY OF SCLERODERMA<I> </P></I> <P>141. ASSESSING DISEASE ACTIVITY AND OUTCOME IN SYSTEMATIC SCLEROSIS (SCLERODERMA)</P> <P>142. CLINICAL FEATURES OF SYSTEMIC SCLEROSIS<I> </P></I> <P>143. ETIOLOGY AND PATHOGENESIS OF SYSTEMIC SCLEROSIS<I> </P></I> <P>144. MANAGEMENT OF SYSTEMIC SCLEROSIS </P> <P>145. PULMONARY MANAGEMENT OF SYSTEMIC SCLEROSIS<I> </P></I> <P>146. RAYNAUD'S PHENOMONEN<I> </P></I> <P>147. LOCALIZED SCLERODERMA AND SCLERODERMA-LIKE SYNDROMES</P> <P>148. CLINICAL FEATURES, CLASSIFICATION, AND EPIDEMIOLOGY OF INFLAMMATORY MUSCLE DISEASE<I> </P></I> <P>149. INFLAMMATORY MUSCLE DISEASE—ETIOLOGY AND PATHOGENESIS</P> <P>150. MANAGEMENT OF INFLAMMATORY MUSCLE DISEASE</P> <P>151. METABOLIC, DRUG-INDUCED, AND OTHER NON-INFLAMMATORY MYOPATHIES<I> </P></I> <P>152. OVERLAP SYNDROMES</P> <P><B>SECTION 11: THE VASCULITIDES</B></P> <P>153. CLASSIFICATION AND EPIDEMIOLOGY OF VASCULITIS<I> </P></I> <P>154. BIOLOGY AND IMMUNOPATHOGENESIS OF VASCULITIS</P> <P>155. POLYARTERITIS NODOSA AND COGAN'S SYNDROME<I> </P></I> <P>156. POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS<I> </P></I> <P>157. ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS<I> </P></I> <P>158. TAKAYASU'S ARTERITIS</P> <P>159. BEHÇET'S SYNDROME<I> </P></I> <P>160. KAWASAKI DISEASE<I> </P></I> <P>161. HENOCH-SCHÖNLEIN PURPURA/IMMUNOGLOBULIN-A VASCULITIS<I> </P></I> <P>162. CUTANEOUS VASCULITIS AND PANNICULITIS<I> </P></I> <P>163. CRYOGLOBULINEMIA<I> </P></I> <P>164. PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM</P> <P><B>SECTION 12: OTHER SYSTEMIC ILLNESSES</B></P> <P>165. MONOGENIC AUTOINFLAMMATORY DISEASES<I> </P></I> <P>166. SARCOIDOSIS</P> <P>167. RELAPSING POLYCHONDRITIS<I> </P></I> <P>168. AMYLOIDOSIS</P> <P>169. DIGITAL CLUBBING AND HYPERTROPHIC OSTEOARTHROPATHY<I> </P></I> <P>170. MISCELLANEOUS ARTHROPATHIES<I> </P></I> <P><B>SECTION 13: OSTEOARTHRITIS AND RELATED DISORDERS</B></P> <P>171. OSTEOARTHRITIS: EPIDEMIOLOGY AND CLASSIFICATION<I> </P></I> <P>172. LOCAL AND SYSTEMIC RISK FACTORS FOR INCIDENCE AND PROGRESSION OF OSTEOARTHRITIS<I> </P></I> <P>173. CLINICAL FEATURES OF OSTEOARTHRITIS</P> <P>174. ANIMAL MODELS OF OSTEOARTHRITIS<I> </P></I> <P>175. PATHOGENESIS AND PATHOLOGY OF OSTEOARTHRITIS<I> </P></I> <P>176. GENETICS OF OSTEOARTHRITIS<I> </P></I> <P>177. IMAGING OF OSTEOARTHRITIS<I> </P></I> <P>178. ASSESSMENT OF THE PATIENT WITH OSTEOARTHRITIS AND MEASUREMENT OF OUTCOMES<I> </P></I> <P>179. PRECLINICAL OSTEOARTHRITIS</P> <P>180. ASSESSMENT OF IMAGING OUTCOMES IN OSTEOARTHRITIS</P> <P>181. MANAGEMENT OF OSTEOARTHRITIS<I> </P></I> <P>182. DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS</P> <P>183. NEUROPATHIC ARTHROPATHY<I> </P></I> <P>184. OSTEONECROSIS<I> </P></I> <P>185. RARE OSTEOARTHRITIS: OCHRONOSIS AND KASHIN-BECK DISEASE</P> <P><B>SECTION 14: CRYSTAL-RELATED ARTHROPATHIES</B></P> <P>186. EPIDEMIOLOGY OF GOUT</P> <P>187. ETIOLOGY AND PATHOGENESIS OF GOUT<I> </P></I> <P>188. CLINICAL GOUT</P> <P>189. THE MANAGEMENT OF GOUT AND HYPERURICEMIA</P> <P>190. CALCIUM PYROPHOSPHATE CRYSTAL-ASSOCIATED ARTHROPATHY<I> </P></I> <P>191. BASIC CALCIUM PHOSPHATE CRYSTAL DEPOSITION DISEASE</P> <P>192. OTHER CRYSTAL-RELATED ARTHROPATHIES<I> </P></I> <P><B>SECTION 15: ENDOCRINE AND HEMOGLOBIN-RELATED ARTHRITIS AND STORAGE DISEASES</B></P> <P>193. RHEUMATOID MANIFESTATIONS OF ENDOCRINE AND LIPID DISEASE</P> <P>194. HEMOPHILIA AND VON WILLEBRAND DISEASE</P> <P>195. JOINT AND BONE LESIONS IN HEMOGLOBINOPATHIES<I> </P></I> <P>196. HEMOCHROMATOSIS</P> <P><B>SECTION 16: METABOLIC BONE DISEASE</B></P> <P>197. EPIDEMIOLOGY AND CLASSIFICATION OF OSTEOPOROSIS<I> </P></I> <P>198. CLINICAL FEATURES OF OSTEOPOROSIS</P> <P>199. PATHOGENESIS OF OSTEOPOROSIS<I> </P></I> <P>200. BIOCHEMICAL MARKERS IN BONE DISEASE<I> </P></I> <P>201. MANAGEMENT OF OSTEOPOROSIS<I> </P></I> <P>202. GLUCOCORTICOID-INDUCED OSTEOPOROSIS<I> </P></I> <P>203. OSTEOMALACIA AND RICKETS</P> <P>204. PRIMARY HYPERPARATHYROIDISM: RHEUMATOLOGIC MANIFESTATIONS AND BONE DISEASE<I> </P></I> <P>205. RENAL OSTEODYSTROPHY</P> <P>206. PAGET DISEASE OF BONE</P> <P><B>SECTION 17: HERITABLE DISEASE AND TUMORS OF BONE AND CONNECTIVE TISSUE</B></P> <P>207. GAUCHER DISEASE<I> </P></I> <P>208. MUCOPOLYSACCHARIDOSES</P> <P>209. HERITABLE CONNECTIVE TISSUE DISORDERS</P> <P>210. HYPERMOBILITY SYNDROME<I> </P></I> <P>211. SKELETAL DYSPLASIAS</P> <P>212. BONE TUMORS</P>

REUMATOLOGIA
Llibres relacionats
ISBN: 9788491133070 KELLEY Y FIRESTEIN. TRATADO DE REUMATOLOGÍA + EXPERTCONSULTKELLEY Y FIRESTEIN. TRATADO DE ...
9788491133070
Mayo 2018
En Stock!
384.62€ S/I
365,39€ S/I
ISBN: 9788491102816 TRATADO DE ENFERMEDADES REUMATICAS DE LA S.E.R.TRATADO DE ENFERMEDADES REUMATICAS DE ...
9788491102816
Abril 2018
En Stock!
96.15€ S/I
91,34€ S/I
ISBN: 9788498359855 REUMATOLOGIA CLINICAREUMATOLOGIA CLINICA
9788498359855
Junio 2017
En Stock!
65.38€ S/I
62,11€ S/I
ISBN: 9780323316965 KELLEY AND FIRESTEIN'S TEXTBOOK OF RHEUMATOLOGY, 2-VOLUME SETKELLEY AND FIRESTEIN'S TEXTBOOK OF ...
9780323316965
Agosto 2016
En Stock!
377.99€ S/I
359,09€ S/I
ISBN: 9780727919545 EULAR. TEXTBOOK OF RHEUMATIC DISEASESEULAR. TEXTBOOK OF RHEUMATIC DISEASES
9780727919545
Julio 2015

P.V.P.: Consultar